See also
ˇ Show More
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
GlaxoSmithKline PLC, Consolidated Statement of Comprehensive Income
USD $ in millions, translated from GBP £
| 12 months ended | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|---|---|
 |
Profit for the year | |
|
|
|
|
|
Exchange movements on overseas net assets and net investment hedges | |
|
|
|
|
|
Reclassification of exchange on liquidation or disposal of overseas subsidiaries | |
|
|
|
|
|
Tax on exchange movements | |
|
|
|
|
|
Fair value movements on available-for-sale investments | |
|
|
|
|
|
Deferred tax on fair value movements on available-for-sale investments | |
|
|
|
|
|
Reclassification of fair value movements on available-for-sale investments | |
|
|
|
|
|
Deferred tax reversed on reclassification of available-for-sale investments | |
|
|
|
|
|
Fair value movements on cash flow hedges | |
|
|
|
|
|
Deferred tax on fair value movements on cash flow hedges | |
|
|
|
|
|
Reclassification of cash flow hedges to income statement | |
|
|
|
|
|
Fair value movement on subsidiary acquisition | |
|
|
|
|
|
Cash flow hedge reclassified to goodwill | |
|
|
|
|
|
Actuarial losses on defined benefit plans | |
|
|
|
|
|
Deferred tax on actuarial movements in defined benefit plans | |
|
|
|
|
|
Share of other comprehensive expense of associates and joint ventures | |
|
|
|
|
|
Other comprehensive income (expense) for the year | |
|
|
|
|
|
Comprehensive income for the year | |
|
|
|
|
|
Comprehensive income for the year attributable to non-controlling interests | |
|
|
|
|
|
Comprehensive income for the year attributable to shareholders | |
|
|
|
|
| Item | Description | The company |
|---|---|---|
| Exchange movements on overseas net assets and net investment hedges | Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity, net of tax, attributable to the parent entity. | GlaxoSmithKline PLC's exchange movements on overseas net assets and net investment hedges increased from 2009 to 2010 but then declined significantly from 2010 to 2011. |
| Fair value movements on available-for-sale investments | Appreciation or loss in value (before reclassification adjustment) of the total of unsold securities during the period being reported on, net of tax. Reclassification adjustments include: (1) the unrealized holding gain (loss), net of tax, at the date of the transfer for a debt security from the held-to-maturity category transferred into the available-for-sale category. Also includes the unrealized gain (loss) at the date of transfer for a debt security from the available-for-sale category transferred into the held-to-maturity category; (2) the unrealized gains (losses) realized upon the sale of securities, after tax; and (3) the unrealized gains (losses) realized upon the write-down of securities, after tax. | GlaxoSmithKline PLC's fair value movements on available-for-sale investments increased from 2009 to 2010 but then declined significantly from 2010 to 2011. |
| Reclassification of fair value movements on available-for-sale investments | Reclassification adjustment for unrealized gains or losses realized upon the sale of securities, after tax. | GlaxoSmithKline PLC's reclassification of fair value movements on available-for-sale investments increased from 2009 to 2010 but then declined significantly from 2010 to 2011. |
| Fair value movements on cash flow hedges | Net of tax effect change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges, after taxes, that is attributable to the parent entity. A cash flow hedge is a hedge of the exposure to variability in the cash flows of a recognized asset or liability or a forecasted transaction that is attributable to a particular risk. The change includes an entity's share of an equity investee's increase (decrease) in deferred hedging gains or losses. | GlaxoSmithKline PLC's fair value movements on cash flow hedges declined from 2009 to 2010 but then increased from 2010 to 2011 exceeding 2009 level. |
| Actuarial losses on defined benefit plans | Net changes to accumulated comprehensive income during the period related to benefit plans, after tax, attributable to the parent entity. | GlaxoSmithKline PLC's actuarial losses on defined benefit plans increased from 2009 to 2010 but then declined significantly from 2010 to 2011. |
| Comprehensive income for the year attributable to shareholders | The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. | GlaxoSmithKline PLC's comprehensive income for the year attributable to shareholders declined from 2009 to 2010 but then increased from 2010 to 2011 not reaching 2009 level. |
May 23, 2012